Abstract: This medicament, which contains, together or separately in combination with a CDK inhibitor, an antibody or a fragment thereof having an immunological reactivity with a CAPRIN-1 protein, is useful for treating and/or preventing cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202517014724-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [20-02-2025(online)].pdf | 2025-02-20 |
| 2 | 202517014724-STATEMENT OF UNDERTAKING (FORM 3) [20-02-2025(online)].pdf | 2025-02-20 |
| 4 | 202517014724-Sequence Listing in txt [20-02-2025(online)].txt | 2025-02-20 |
| 5 | 202517014724-Sequence Listing in PDF [20-02-2025(online)].pdf | 2025-02-20 |
| 6 | 202517014724-REQUEST FOR EXAMINATION (FORM-18) [20-02-2025(online)].pdf | 2025-02-20 |
| 7 | 202517014724-PROOF OF RIGHT [20-02-2025(online)].pdf | 2025-02-20 |
| 8 | 202517014724-POWER OF AUTHORITY [20-02-2025(online)].pdf | 2025-02-20 |
| 9 | 202517014724-FORM 18 [20-02-2025(online)].pdf | 2025-02-20 |
| 10 | 202517014724-FORM 1 [20-02-2025(online)].pdf | 2025-02-20 |
| 11 | 202517014724-FIGURE OF ABSTRACT [20-02-2025(online)].pdf | 2025-02-20 |
| 12 | 202517014724-DRAWINGS [20-02-2025(online)].pdf | 2025-02-20 |
| 13 | 202517014724-DECLARATION OF INVENTORSHIP (FORM 5) [20-02-2025(online)].pdf | 2025-02-20 |
| 14 | 202517014724-COMPLETE SPECIFICATION [20-02-2025(online)].pdf | 2025-02-20 |
| 15 | 202517014724-MARKED COPIES OF AMENDEMENTS [04-03-2025(online)].pdf | 2025-03-04 |
| 16 | 202517014724-FORM 13 [04-03-2025(online)].pdf | 2025-03-04 |
| 17 | 202517014724-AMMENDED DOCUMENTS [04-03-2025(online)].pdf | 2025-03-04 |
| 18 | 202517014724-certified copy of translation [13-05-2025(online)].pdf | 2025-05-13 |
| 19 | 202517014724-FORM 3 [18-08-2025(online)].pdf | 2025-08-18 |